TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/24/24 20:24 | 9/20/24 | EWTX | Edgewise Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Donovan Joanne M. | CO | O | CMO | S | -203 | 28.29 | 0 | -7 | -33 | 15 | D | ||||||||||||||
5/3/24 18:27 | 5/1/24 | EWTX | Edgewise Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Donovan Joanne M. | CO | O | CMO | M.d | 0 | 0.00 | 0 | 10 | 110 | 20 | D | ||||||||||||||
5/3/24 18:27 | 5/2/24 | EWTX | Edgewise Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Donovan Joanne M. | CO | O | CMO | S.d | -70 | 18.91 | 0 | -4 | -16 | 20 | D | ||||||||||||||
5/3/23 18:25 | 5/1/23 | EWTX | Edgewise Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Donovan Joanne M. | CO | O | CMO | M.d | 0 | 0.00 | 0 | 10 | 10 | D | |||||||||||||||
5/3/23 18:25 | 5/2/23 | EWTX | Edgewise Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Donovan Joanne M. | CO | O | CMO | S.d | -29 | 8.90 | 0 | -3 | -25 | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |